BCRX
BioCryst Pharmaceuticals Inc
Price:  
6.24 
USD
Volume:  
3,520,104.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCRX WACC - Weighted Average Cost of Capital

The WACC of BioCryst Pharmaceuticals Inc (BCRX) is 8.6%.

The Cost of Equity of BioCryst Pharmaceuticals Inc (BCRX) is 10.70%.
The Cost of Debt of BioCryst Pharmaceuticals Inc (BCRX) is 5.50%.

Range Selected
Cost of equity 8.50% - 12.90% 10.70%
Tax rate 0.10% - 0.50% 0.30%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.7% - 10.6% 8.6%
WACC

BCRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1 1.44
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.50% 12.90%
Tax rate 0.10% 0.50%
Debt/Equity ratio 0.66 0.66
Cost of debt 4.00% 7.00%
After-tax WACC 6.7% 10.6%
Selected WACC 8.6%